Thomas Hayman
استادیار · Radiation Oncology
Max Planck Institute of Molecular Cell Biology and Geneticsمعرفی
Dr. Thomas Hayman is an Assistant Professor of Therapeutic Radiology at Yale School of Medicine and an active physician-scientist at Yale Cancer Center. His primary affiliations include leadership roles in the Center for Thoracic Cancers, Head and Neck Cancers Program, and DNA Damage and Genome Integrity Program. He directs the Hayman Laboratory, which investigates mechanisms of DNA damage resistance with translational applications in radiation oncology.
His research focuses on:
- Molecular determinants of tumor radiosensitivity
- DNA damage response pathways
- STING-mediated cell death mechanisms
- Novel radiosensitization strategies (e.g., PLK4 inhibition)
- Translational approaches for lung, head/neck, and gastrointestinal cancers
Recent publications demonstrate his work spans from basic science (CRISPR screens identifying STING as a radiosensitivity determinant) to clinical research (optimizing radiotherapy protocols for lung metastases). His 2025 publications focus on targeting PLK4 to overcome radiation resistance in NSCLC.
Awards & Honors:
- Holman Research Pathway Fellowship
As a clinician, he specializes in advanced radiation techniques including stereotactic radiosurgery and SBRT for thoracic, head/neck, and genitourinary malignancies. He completed his MD/PhD at University of South Florida and residency at Yale New Haven Hospital.
